Centene Stock Jumps 6.2% as Reddit Traders Buy the Dip Analysts Won't Touch

Centene (CNC) shares have recently rebounded, largely driven by retail investor bullishness on valuation metrics despite a cautious stance from Wall Street analysts. Retail traders are buying the dip, citing the company's deep value (0.106x sales), Q3 operational improvements, and 66% revenue growth in Medicare, while analysts remain concerned by negative GAAP EPS due to a $6.7 billion goodwill impairment and a rising 92.7% health benefits ratio. The company's raised full-year adjusted EPS guidance and improved SG&A suggest some operational momentum, but the sustainability of these improvements and medical cost management remain critical for future performance.

Analysis

Centene (CNC) shares have rebounded 6.2% from their November 10 low of $34.25, reaching $36.38, following an 8.8% single-day drop. This recovery is primarily fueled by strong retail investor bullishness, particularly on r/wallstreetbets, who are buying the dip. This contrasts sharply with Wall Street analysts, where 14 of 20 maintain "Hold" ratings, highlighting a significant divergence in market sentiment.

Retail investors are attracted to CNC's deep value, trading at 0.106x sales and 0.849x book value. They cite recent operational momentum, including a Q3 earnings beat and 66% year-over-year revenue growth in Medicare, alongside the CEO's August share purchase, as catalysts for a potential turnaround.

Professional analysts, however, remain concerned by profitability issues, evidenced by a -$10.67 GAAP EPS (TTM) and a -21.9% ROE. A $6.7 billion goodwill impairment in Q3 and a rising health benefits ratio (HBR) of 92.7% from 89.2% underscore these margin pressures, justifying the cautious institutional stance.

Management has raised full-year adjusted EPS guidance to $2.00 and improved the SG&A ratio to 7.0%, signaling some cost control. The forward outlook depends on sustaining these operational improvements and managing the elevated HBR. Investors should monitor Medicare Advantage enrollment trends and the HBR's trajectory for future performance indicators.

Key Decisions for Investors

• Monitor the sustainability of Centene's operational improvements, particularly the health benefits ratio (HBR) and Medicare Advantage enrollment trends, as these are critical for future profitability.
• Evaluate the company's valuation against its profitability challenges, considering the significant divergence between retail and institutional sentiment regarding its long-term prospects.
• Assess the impact of the $6.7 billion goodwill impairment and negative GAAP EPS on long-term value, weighing it against management's raised adjusted EPS guidance and improved SG&A efficiency.